Medscape

FDA Changes Drug Trial Guidance: Experts Take Sides

The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
PRIMETIMER on MSN

New analysis narrows possible sources of the Amaterasu cosmic ray

New analysis by Francesca Capel and Nadine Bourriche narrows possible sources of the Amaterasu cosmic ray, suggesting nearby galaxies like M82 rather than the Local Void.
PharmExec

The Next Generation of Trial Designs: Supplementing Trials with Real-World Data

Real-world data (RWD) is transforming clinical research, augmenting existing randomized controlled trial (RCT) data to de-risk studies and improve generalizability. With regulators setting clearer ...
Frontiers

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson’s disease: a Bayesian network meta-analysis

Background and Objectives: Quality of life (QoL) is a critical outcome in the management of Parkinson’s disease (PD), and is often affected more by non-motor symptoms (NMS) than motor features. While ...
The Manila Times

BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research

BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue derived products for advanced wound care, today ...
IEEE

Bayesian-Optimized Multi-Task Gaussian Process Regression With Composite Kernels for Soybean Oil Futures Forecasting

Abstract: Accurate forecasting of agricultural commodity prices is critical for economic stability and strategic decision-making, yet remains challenging owing to nonlinear dynamics and multifactorial ...
IEEE

Bayesian Inference and Hypothesis Driven Methods for Neuroimaging and Biomedical Data Analysis

Abstract: This paper describes a novel brain and cellular data analysis. Bayesian reasoning and hierarchical models provide important information. Bayesian principles continually anticipate model ...
Opinion
The BMJOpinion

FDA is now “open to bayesian statistics”: transformational change or new Pandora’s box?

The US Food and Drug Administration (FDA) is now “open to bayesian statistics,” contrasting this with the frequentist approach that the agency and the drug industry have historically relied on for ...
Morningstar

Professor Sarfaraz Niazi's Scientific Framework Adopted as FDA Modernizes Clinical Trial Evaluation Through Bayesian Methods

WASHINGTON, Jan. 20, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing ...